Physician profile
William B Simpson
NPI 1235246406
$1,197.55
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $127 · 2021: $152 · 2022: $222 · 2023: $315 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $342.20 | 2019-2023 | Ubrelvy, Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $161.43 | 2020-2023 | |
| Boston Scientific Corporation | $142.33 | 2019-2024 | Ams 700 |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $51.58 | 2022-2023 | Aptima |
| Evofem Biosciences, INC. | $49.48 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $46.40 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $44.45 | 2023 | Myfembree |
| Eisai INC. | $44.09 | 2020-2021 | |
| Ethicon US, LLC | $37.43 | 2020 | |
| Allergan, INC. | $28.76 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.70 | 2019-2022 | |
| Therapeuticsmd, INC. | $19.94 | 2019 | |
| Scynexis, INC. | $18.09 | 2022 | |
| Duchesnay USA Incorporated | $17.02 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $14.81 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.21 | 2019 | |
| Myovant Sciences INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.